Atossa Therapeutics
ATOS
#9946
Rank
NZ$80.89 M
Marketcap
NZ$9.39
Share price
4.99%
Change (1 day)
687.78%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.44. In 2024 the company made an earnings per share (EPS) of NZ-$0.35 an increase over its 2023 EPS that were of NZ-$0.42.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4219.48%
2024NZ-$0.35-16.67%
2023NZ-$0.4214.29%
2022NZ-$0.3716.67%
2021NZ-$0.32-90.86%
2020NZ-$3.45-2.96%
2019NZ-$3.55-63.09%
2018NZ-$9.63-49.63%
2017NZ-$19.12-57.87%
2016NZ-$45.38-74.01%
2015NZ-$174.60-9.18%
2014NZ-$192.25-12.86%
2013NZ-$220.6170.73%
2012NZ-$129.2234.08%
2011NZ-$96.37263.47%
2010NZ-$26.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.50-4,555.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.53-3,648.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$18.44-4,312.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.54 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.37-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA